McLoughlin Margaret
SEC CIK 1770823 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| QNCX | Quince Therapeutics, Inc. | Dir | 8,000 | $9,840 | $661.6K | 5 | 2021-08-16 | 2023-08-08 |
Most active insiders at QNCX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Benatti Luca | Dir | — | $173.5K |
| 2 | Hannah Brendan | COO, CCO, CBO | — | — |
| 3 | Thye Dirk | CEO, CMO, Dir | — | — |
McLoughlin Margaret made no open-market trades at QNCX in the last 12 months.
Transactions 5
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-08-09 | 2023-08-08 | QNCX | Quince Therapeutics, Inc. | McLoughlin Margaret | Dir | P - Purchase | $1.23 | +8,000 | 8,000 | New | +$9,840 | |
| D | 2021-10-12 | 2021-10-08 | QNCX | Quince Therapeutics, Inc. | McLoughlin Margaret | Dir | S - Sale+OE | $88.93 | -1,000 | 0 | -100% | -$88.9K |
| D | 2021-10-12 | 2021-10-08 | QNCX | Quince Therapeutics, Inc. | McLoughlin Margaret | Dir | M - OptEx | $17.00 | +1,000 | 1,000 | New | +$17.0K |
| DM | 2021-08-18 | 2021-08-16 | QNCX | Quince Therapeutics, Inc. | McLoughlin Margaret | Dir | S - Sale+OE | $95.44 | -6,000 | 0 | -100% | -$572.6K |
| D | 2021-08-18 | 2021-08-16 | QNCX | Quince Therapeutics, Inc. | McLoughlin Margaret | Dir | M - OptEx | $17.00 | +6,000 | 6,000 | New | +$102.0K |
Purchase Sale Sale after option exercise All abbreviations